Correction to: Cell Biochemistry and Biophysics (2025) 83:1097–1104; https://doi.org/10.1007/s12013-024-01544-x; published online 24 September 2024

In this article, Figure 2 appeared incorrectly. For completeness and transparency, the old incorrect and corrected versions of Figure 2 are displayed below.

The incorrect version of Fig. 2.

Fig. 2 Effects of CA and KN93 on lipopolysaccharide (LPS)-induced A549 cell viability. A549 cells were induced with 1 μg/mL LPS for 24 h and treated with different concentrations of CA (10, 50, and 200 μg/mL) or 10 μmol/L KN93. A Cells viability was assessed via MTT assay. B LDH activity was assessed via LDH assay. C A549 cell apoptosis was assessed via flow cytometry. D Quantification of apoptotic A549 cells. E, F Determination of apoptosis-related protein (cleaved-caspase-3, Bcl-2-associated X [Bax], and Bcl-2) levels via western blotting. **P < 0.01 vs. control; #P < 005 and ##P < 0.01 vs. LPS treatment group

Correct version of Fig. 2.

Fig. 2 Effects of CA and KN93 on lipopolysaccharide (LPS)-induced A549 cell viability. A549 cells were induced with 1 μg/mL LPS for 24 h and treated with different concentrations of CA (10, 50, and 200 μg/mL) or 10 μmol/L KN93. A Cells viability was assessed via MTT assay. B LDH activity was assessed via LDH assay. C A549 cell apoptosis was assessed via flow cytometry. D Quantification of apoptotic A549 cells. E, F Determination of apoptosis-related protein (cleaved-caspase-3, Bcl-2-associated X [Bax], and Bcl-2) levels via western blotting. **P < 0.01 vs. control; #P < 005 and ##P < 0.01 vs. LPS treatment group

The original article has been corrected.